Paper

Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes.

Published Jul 23, 1997 · DOI · Y. Ishii, K. Muraki, A. Kurihara

European journal of pharmacology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Sematilide selectively blocks the rapidly activating delayed rectifier K+ current in atrial myocytes, supporting its usefulness as a class III antiarrhythmic agent.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes.

References

Citations